Send this to a friend

Insulet moving to Acton, switching CEOs

Insulet, a manufacturer of the wearable OmniPod insulin system for diabetes patients, will move its worldwide headquarters in mid-December from Billerica to a $100-million Acton facility. CEO Patrick Sullivan will retire Dec. 31 and hand over the reigns to Shacey Petrovic, the firm's president and chief operating officer.
Why retire now?
Sullivan: When I first came to th ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media